Absent Mandatory Listing, US FDA Acknowledges Its Supplement Directory Isn’t Comprehensive
Executive Summary
Two weeks after Commissioner Califf notes he supports mandatory listing of supplements and two months after previous session of Congress ended without imposing requirement, agency is doing what it can to publish information about ingredients in supplements sold in the country.
You may also be interested in...
House Members Take STAND On Tianeptine As ‘Unregulated Drug’ In Supplements
Reps. Panetta and Pfluger introduce Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act to make tianeptine a schedule III controlled substance a day after FDA posts latest alert to warn consumers against using products containing ingredient known as “gas station heroin.”
Tianeptine Rings Latest Unapproved Drug Alarm, Followed By Echo About Lack Of FDA Regulation
Tianeptine isn’t approved as drug in US nor allowed for use as dietary ingredient or food additive. FDA has warned multiple firms selling tianeptine-containing products and federal prosecutors recently announced guilty plea from man who sold the drug to consumers.
Good ‘Fit’ For Regulation Shifting US FDA's ODSP Into Larger Food Safety Program – Director
ODSP Director Cara Welch spoke about food programs structure and other supplement industry regulatory news days before first day on the job for agency’s first deputy commissioner for human foods, a post added in the human foods reorganization plan.